Xiaofang Dai

2.3k total citations · 1 hit paper
45 papers, 1.7k citations indexed

About

Xiaofang Dai is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaofang Dai has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaofang Dai's work include Nanoplatforms for cancer theranostics (6 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). Xiaofang Dai is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). Xiaofang Dai collaborates with scholars based in China, United States and Singapore. Xiaofang Dai's co-authors include Yun Xia, Gang Wu, Hongxia Zhou, Qi Han, Jipeng Guo, Bing-Fei Xu, Zhenyu Li, Yuhui Yang, Chunyan Li and Tao Liu and has published in prestigious journals such as ACS Nano, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Xiaofang Dai

43 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptosis: A Novel Anti-tumor Action for Cisplatin

2017 606 citations Xiaofang Dai, Gang Wu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaofang Dai China	19	862	628	627	378	287	45	1.7k
Bufu Tang China	23	1.1k 1.3×	699 1.1×	727 1.2×	321 0.8×	291 1.0×	85	1.8k
Jinhai Fan China	27	912 1.1×	414 0.7×	381 0.6×	461 1.2×	170 0.6×	109	2.0k
Wence Zhou China	18	584 0.7×	405 0.6×	452 0.7×	574 1.5×	213 0.7×	90	1.7k
Jin Tao China	24	910 1.1×	352 0.6×	442 0.7×	502 1.3×	342 1.2×	52	1.9k
Jacinta Serpa Portugal	26	1.1k 1.2×	257 0.4×	501 0.8×	319 0.8×	263 0.9×	77	2.0k
Xiaomeng Dai China	24	826 1.0×	389 0.6×	504 0.8×	644 1.7×	466 1.6×	54	1.9k
Huan Shi China	21	555 0.6×	307 0.5×	378 0.6×	462 1.2×	268 0.9×	55	1.5k
Jiancheng Zhou China	25	1.3k 1.5×	463 0.7×	546 0.9×	880 2.3×	195 0.7×	48	2.1k
Zhisu Liu China	27	1.1k 1.3×	230 0.4×	646 1.0×	316 0.8×	170 0.6×	70	1.8k

Countries citing papers authored by Xiaofang Dai

Since Specialization

Citations

This map shows the geographic impact of Xiaofang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Dai more than expected).

Fields of papers citing papers by Xiaofang Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Dai. The network helps show where Xiaofang Dai may publish in the future.

Co-authorship network of co-authors of Xiaofang Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofang Dai. A scholar is included among the top collaborators of Xiaofang Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofang Dai. Xiaofang Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dai, Xiaofang, et al.. (2025). Can Digital Economy Facilitate Household Clean Cooking Fuel Transition? Empirical Evidence from China. Sustainability. 17(1). 288–288. 2 indexed citations

Ji, Wei, Zesheng Ji, Yanping Chen, et al.. (2025). Gender differences in preferences, gateway effects, and potential motivations among e-cigarette users in China. Frontiers in Public Health. 13. 1417218–1417218.

Yao, S. J., et al.. (2024). A multifunctional metal-based nanozyme for CT/PTI-guided photothermal/starvation/chemodynamic therapy against colon tumor. Journal of Materials Chemistry B. 13(5). 1781–1793. 2 indexed citations

Wu, Yan, Dan Zhang, Xiaofang Dai, et al.. (2024). Micropeptides: potential treatment strategies for cancer. Cancer Cell International. 24(1). 134–134. 13 indexed citations

Guo, Yusheng, et al.. (2024). Re-analysis of single cell and spatial transcriptomics data reveals B cell landscape in gastric cancer microenvironment and its potential crosstalk with tumor cells for clinical prognosis. Journal of Translational Medicine. 22(1). 807–807. 4 indexed citations

Chen, Yisong, et al.. (2024). A review of China's automotive industry policy: Recent developments and future trends. Journal of Traffic and Transportation Engineering (English Edition). 11(5). 867–895. 7 indexed citations

Wang, Qingshui, Rongfu Huang, Shanshan Chen, et al.. (2024). LC-MS/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer. Methods. 222. 100–111. 11 indexed citations

Dai, Xiaofang, Jingwei Ye, Qiaoqing Xu, et al.. (2023). Effects of dietary enzymatically treated Artemisia annua L. in low fish meal diet on growth, antioxidation, metabolism and intestinal health of Micropterus salmoides. Aquaculture Reports. 33. 101843–101843. 3 indexed citations

Hu, Han, Shijie Yao, Qi Xu, et al.. (2023). Protein-coated cobalt oxide–hydroxide nanospheres deliver photosensitizer IR780 iodide for near-infrared light-triggered photodynamic/photothermal/chemodynamic therapy against colon cancer. Journal of Materials Chemistry B. 11(38). 9185–9200. 4 indexed citations

10.

Li, Ruiqi, Lian Chen, Qing Liang, et al.. (2023). Macrophage Membrane‐Coated Nanoparticles Sensitize Glioblastoma to Radiation by Suppressing Proneural–Mesenchymal Transformation in Glioma Stem Cells. Advanced Functional Materials. 33(37). 18 indexed citations

11.

Li, Zhenyu, Xiaoshu Zhou, Shuai Wang, et al.. (2023). The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study. Translational Cancer Research. 12(4). 904–912.

12.

Dai, Xiaofang, et al.. (2023). Novel lipidomes profile and clinical phenotype identified in pneumoconiosis patients. Journal of Health Population and Nutrition. 42(1). 55–55. 6 indexed citations

13.

Dong, Xiaorong, Yu Huang, Tienan Yi, et al.. (2022). Intrapleural infusion of tumor cell-derived microparticles packaging methotrexate or saline combined with pemetrexed-cisplatin chemotherapy for the treatment of malignant pleural effusion in advanced non-squamous non-small cell lung cancer: A double-blind, randomized, placebo-controlled study. Frontiers in Immunology. 13. 1002938–1002938. 12 indexed citations

14.

Hu, Han, Ruiqi Li, Piao Huang, et al.. (2022). BSA-coated β-FeOOH nanoparticles efficiently deliver the photosensitizer chlorin e6 for synergistic anticancer PDT/CDT. Colloids and Surfaces B Biointerfaces. 222. 113117–113117. 12 indexed citations

15.

Wu, Jia‐Rui, Zhanjie Zhang, Changfeng Yi, et al.. (2021). Synthesis of Monodisperse ZIF-67@CuSe@PVP Nanoparticles for pH-Responsive Drug Release and Photothermal Therapy. ACS Biomaterials Science & Engineering. 8(1). 284–292. 34 indexed citations

16.

Zhou, Mengting, Jun Fan, Zhenyu Li, et al.. (2019). Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer. Respiratory Research. 20(1). 248–248. 18 indexed citations

17.

Huang, Yumei, Kaishun Hu, Sheng Zhang, et al.. (2018). S6K1 phosphorylation-dependent degradation of Mxi1 by β-Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer. Theranostics. 8(5). 1286–1300. 34 indexed citations

18.

Dai, Xiaofang, et al.. (2011). Association Between Insulin-Like Growth Factor Binding Protein-3 Promoter Polymorphism of −1590 C>A and Lung Cancer Susceptibility in a Chinese Han Population. Genetic Testing and Molecular Biomarkers. 15(5). 301–306. 5 indexed citations

19.

Dai, Xiaofang, et al.. (2009). Clinical studies of recombinant human thrombopoietin in treatment of gemzar and cisplatin-induced thrombocytopenia in patients with non-small cell lung cancer. Zhonghua zhongliu fangzhi zazhi. 374–376. 1 indexed citations

20.

Dai, Xiaofang, et al.. (2009). Low dose hyper-radiosensitivity in human lung cancer cell line A549 and its possible mechanisms. Journal of Huazhong University of Science and Technology [Medical Sciences]. 29(1). 101–106. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact